The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial

Table 3

Mean values of symptom severity of subjective hypomnesis/memory loss (SML) and subjective attention deficit (SAD) (mean ± s.d.) before and after 12 weeks of BrainPower Advanced and placebo intervention.

Self-reported deficits	Intervention	Before intervention	After intervention	Relative to baseline (= 1)
Subjective hypomnesis/memory loss (SML)	BrainPower	3.77 ± 0.89	2.94 ± 0.94	0.779840849
	Placebo	3.43 ± 1.19	2.88 ± 0.77	0.839650146
Subjective concentration/attention deficit (SAD)	BrainPower	3.62 ± 0.99	2.68 ± 0.89	0.740331492
	Placebo	3.25 ± 1.35	2.92 ± 0.94	0.898461538